EPHX2 and early-onset autosomal dominant Alzheimer disease: Although potent inhibitorstargeting each domain are available, sEH-PROTACs offer the uniqueability to simultaneously block both enzymatic functions, mimickingthe sEH knockout phenotype, which has been associated with reducinginflammation, including neuroinflammation, and delaying the progressionof Alzheimer’s disease.